U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 11 of 11

Tests names and labsConditionsGenes, analytes, and microbesMethods

Obesity, susceptibility to, 601665, Autosomal recessive, Autosomal dominant, Multifactorial (CARTPT gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Non syndromic obesity (WES based NGS panel of 22 genes, including analysis of CNVs)

CGC Genetics Unilabs
Portugal
122
  • C Sequence analysis of the entire coding region

Obesity susceptibility (sequence analysis of CARTPT gene)

CGC Genetics Unilabs
Portugal
11
  • C Sequence analysis of the entire coding region

Genomic Unity® Custom Analysis

Variantyx, Inc.
United States
14054
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Severe Obesity (Susceptibility to) , Panel Massive Sequencing (NGS) 18 Genes

Reference Laboratory Genetics
Spain
418
  • C Sequence analysis of the entire coding region

Obesity, mild, early-onset

Bioarray
Spain
11
  • C Sequence analysis of the entire coding region

CARTPT Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clinical Exome

Fulgent Genetics
United States
51294672
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Diabetes-Obesity NGS Panel

Fulgent Genetics
United States
7356
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Obesity, severe, susceptibility to,

MedGene
Slovakia
11
  • C Sequence analysis of the entire coding region

Obesity, severe, susceptibility to,

Praxis fuer Humangenetik Wien
Austria
11
  • C Sequence analysis of the entire coding region

Results: 1 to 11 of 11

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.